JARED DELOACH: Open Payments
NPI 1235766304 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 74 payments from 14 companies in 2025. Trend: 2023 $1,056 · 2024 $1,228 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $256 |
| AstraZeneca Pharmaceuticals LP | 10 | $207 |
| PFIZER INC. | 13 | $182 |
| Lilly USA, LLC | 9 | $149 |
| Viatris Specialty LLC | 5 | $99 |
| Amgen Inc. | 5 | $86 |
| Sumitomo Pharma America, Inc. | 5 | $84 |
| Lundbeck LLC | 4 | $67 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $29 |
Products named: NURTEC ODT, MOUNJARO, AIRSUPRA, VRAYLAR, YUPELRI, GEMTESA, OTEZLA, REXULTI.
Industry payments across MS — which companies pay providers there.
